NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026.

Gerds AT, Gotlib J, Abdelmessieh P, Ali H, Castells M, Chernak BJ, Espinoza-Gutarra MR, Fein Revell R, Green S, Gundabolu K, Hexner E, Jain T, Jamieson CH, Khan I, Kuykendall AT, Madanat YF, Masarova L, McMahon B, Mohan SR, Nadiminti KV, Oh S, Palmer J, Patel AB, Patel AA, Podoltsev N, Rein L, Salit R, Sehl M, Talpaz M, Wadleigh M, Wall SA, Bergman MA, Hochstetler C

Open source

DOI
10.6004/jnccn.2026.0034
Published
2026 Jul
Container
Journal of the National Comprehensive Cancer Network : JNCCN
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.6004/jnccn.2026.0034,
  title = {NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026.},
  author = {Gerds AT and Gotlib J and Abdelmessieh P and Ali H and Castells M and Chernak BJ and Espinoza-Gutarra MR and Fein Revell R and Green S and Gundabolu K and Hexner E and Jain T and Jamieson CH and Khan I and Kuykendall AT and Madanat YF and Masarova L and McMahon B and Mohan SR and Nadiminti KV and Oh S and Palmer J and Patel AB and Patel AA and Podoltsev N and Rein L and Salit R and Sehl M and Talpaz M and Wadleigh M and Wall SA and Bergman MA and Hochstetler C},
  year = {2026},
  journal = {Journal of the National Comprehensive Cancer Network : JNCCN},
  doi = {10.6004/jnccn.2026.0034},
  url = {https://doi.org/10.6004/jnccn.2026.0034}
}

RIS

TY  - JOUR
TI  - NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026.
AU  - Gerds AT
AU  - Gotlib J
AU  - Abdelmessieh P
AU  - Ali H
AU  - Castells M
AU  - Chernak BJ
AU  - Espinoza-Gutarra MR
AU  - Fein Revell R
AU  - Green S
AU  - Gundabolu K
AU  - Hexner E
AU  - Jain T
AU  - Jamieson CH
AU  - Khan I
AU  - Kuykendall AT
AU  - Madanat YF
AU  - Masarova L
AU  - McMahon B
AU  - Mohan SR
AU  - Nadiminti KV
AU  - Oh S
AU  - Palmer J
AU  - Patel AB
AU  - Patel AA
AU  - Podoltsev N
AU  - Rein L
AU  - Salit R
AU  - Sehl M
AU  - Talpaz M
AU  - Wadleigh M
AU  - Wall SA
AU  - Bergman MA
AU  - Hochstetler C
PY  - 2026
JO  - Journal of the National Comprehensive Cancer Network : JNCCN
DO  - 10.6004/jnccn.2026.0034
UR  - https://doi.org/10.6004/jnccn.2026.0034
ER  - 

APA

AT, G., J, G., P, A., H, A., M, C., BJ, C., MR, E., R, F. R., S, G., K, G., E, H., T, J., CH, J., I, K., AT, K., YF, M., L, M., B, M., SR, M., KV, N., S, O., J, P., AB, P., AA, P., N, P., L, R., R, S., M, S., M, T., M, W., SA, W., MA, B., & C, H. (2026). NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026.. Journal of the National Comprehensive Cancer Network : JNCCN. https://doi.org/10.6004/jnccn.2026.0034

Source records